Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Related Articles by Review for PubMed (Select 21386068)

1.

Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism.

Bauer KA.

JAMA. 2011 Apr 6;305(13):1336-45. doi: 10.1001/jama.2011.361. Epub 2011 Mar 8.

PMID:
21386068
2.

[The optimal duration of anticoagulant treatment following pulmonary embolism].

Couturaud F.

Rev Mal Respir. 2011 Dec;28(10):1265-77. doi: 10.1016/j.rmr.2011.04.017. Epub 2011 Nov 3. Review. French.

PMID:
22152935
3.

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism.

Kearon C, Akl EA.

Blood. 2014 Mar 20;123(12):1794-801. doi: 10.1182/blood-2013-12-512681. Epub 2014 Feb 4. Review.

4.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
5.

Venous thromboembolism: risk factors for recurrence.

Zhu T, Martinez I, Emmerich J.

Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):298-310. doi: 10.1161/ATVBAHA.108.182428. Review.

6.

Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.

Kearon C.

J Thromb Thrombolysis. 2011 Apr;31(3):295-300. doi: 10.1007/s11239-011-0573-x. Review.

PMID:
21331558
7.

Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.

de Jong PG, Coppens M, Middeldorp S.

Br J Haematol. 2012 Aug;158(4):433-41. doi: 10.1111/j.1365-2141.2012.09196.x. Epub 2012 Jun 26. Review.

PMID:
22734929
8.

The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.

Prandoni P, Barbar S, Milan M, Vedovetto V, Pesavento R.

Eur J Intern Med. 2014 Jan;25(1):25-30. doi: 10.1016/j.ejim.2013.09.005. Epub 2013 Oct 9. Review.

PMID:
24120221
9.

Duration of anticoagulant therapy for patients with venous thromboembolism.

Garcia D.

Thromb Res. 2008;123 Suppl 1:S62-4. doi: 10.1016/j.thromres.2008.08.019. Epub 2008 Sep 26. Review.

PMID:
18823648
10.

Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy.

Kearon C.

Clin Chest Med. 2010 Dec;31(4):719-30. doi: 10.1016/j.ccm.2010.06.003. Review.

PMID:
21047578
11.

Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.

Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, Poli D, Lim W.

Ann Intern Med. 2008 Oct 7;149(7):481-90, W94. Review.

PMID:
18838728
12.

Optimal duration of anticoagulation in patients with venous thromboembolism.

Prandoni P, Piovella C, Spiezia L, Dalla Valle F, Pesavento R.

Indian J Med Res. 2011 Jul;134:15-21. Review.

13.

Long-term management of patients after venous thromboembolism.

Kearon C.

Circulation. 2004 Aug 31;110(9 Suppl 1):I10-8. Review.

15.

Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.

Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009. Review.

PMID:
20956709
16.

Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.

Rodger M, Carrier M, Gandara E, Le Gal G.

Blood Rev. 2010 Jul-Sep;24(4-5):171-8. doi: 10.1016/j.blre.2010.06.001. Epub 2010 Jul 14. Review.

PMID:
20633967
17.

Treatment of venous thromboembolism.

Wells PS, Forgie MA, Rodger MA.

JAMA. 2014 Feb 19;311(7):717-28. doi: 10.1001/jama.2014.65. Review. Erratum in: JAMA. 2014 Jun 25;311(24):2545.

PMID:
24549552
18.

[Duration of oral anticoagulant therapy in venous thromboembolism].

Pinède L.

Rev Med Interne. 2001 Dec;22(12):1225-36. Review. French.

PMID:
11794893
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk